Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis
Open Access
- 5 May 1999
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 81 (3), 467-470
- https://doi.org/10.1002/(sici)1097-0215(19990505)81:3<467::aid-ijc22>3.0.co;2-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Differential apoptotic response of human melanoma cells to 1α,25-dihydroxyvitamin D3 and its analoguesCell Death & Differentiation, 1998
- Vitamin A metabolism and mRNA expression of retinoid-binding protein and receptor genes in human epidermal melanocytes and melanoma cellsMelanoma Research, 1997
- Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo.The Journal of cell biology, 1996
- Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1996
- Vitamin D Receptor and Growth Inhibition by 1,25-Dihydroxyvitamin D3in Human Malignant Melanoma Cell LinesJournal of Surgical Research, 1996
- VITAMIN D DERIVATIVES IN COMBINATION WITH 9-cis RETINOIC ACID PROMOTE ACTIVE CELL DEATH IN BREAST CANCER CELLSJournal of Molecular Endocrinology, 1995
- Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γBiochemical and Biophysical Research Communications, 1992
- Retinoic Acid Receptor Gene Expression in Human SkinJournal of Investigative Dermatology, 1991
- Human Melanoma Cells: Functional Modulation by Calciotropic HormonesJournal of Investigative Dermatology, 1988
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981